The Trump administration is joining forces with Mark Cuban’s Cost Plus Drugs, Amazon Pharmacy, and GoodRx to add generic medications to the direct-to-consumer drug sales website, TrumpRx, in an attempt to lower healthcare costs ahead of the 2026 midterm elections.At the White House on Monday afternoon, President Donald Trump announced a merger of the TrumpRx platform with several discount pharmacies to expand access to lower-priced generic medications.“By incorporating this massive catalog of low-cost generics at Trumprx.gov, consumers will now have one source to ensure that they’re getting the lowest possible costs on their prescriptions,” Trump said.
The White House and the Department of Health and Human Services launched the TrumpRx platform earlier this year as a direct-to-consumer website to access Most Favored Nation drug prices negotiated between the federal government and pharmaceutical companies for name-brand drugs.
Most Favored Nation drug prices, also known as MFN, have been at the center of the Trump administration’s healthcare affordability efforts. Under the threat of tariffs, the administration has secured deals from more than a dozen companies to sell their products in the United States at the lowest rate they are sold at in other countries.
